Novo Nordisk A/S (NVO)
43.07
-0.94
(-2.14%)
USD |
NYSE |
Sep 11, 16:00
43.05
-0.02
(-0.05%)
After-Hours: 20:00
Novo Nordisk Price : 43.07 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 43.20 | 43.50 | 42.72 | 43.07 | 11.03M |
| Sep 10, 2026 | 44.60 | 44.82 | 44.01 | 44.01 | 6.581M |
| Sep 09, 2026 | 45.00 | 45.40 | 44.52 | 44.56 | 8.834M |
| Sep 08, 2026 | 45.58 | 45.91 | 45.14 | 45.16 | 10.35M |
| Sep 04, 2026 | 46.35 | 46.74 | 46.04 | 46.60 | 6.219M |
| Sep 03, 2026 | 47.99 | 48.00 | 46.56 | 47.51 | 8.770M |
| Sep 02, 2026 | 46.05 | 47.00 | 45.91 | 46.77 | 13.60M |
| Sep 01, 2026 | 45.80 | 46.16 | 45.06 | 45.12 | 9.356M |
| Aug 31, 2026 | 45.28 | 45.61 | 44.95 | 45.33 | 7.607M |
| Aug 28, 2026 | 46.17 | 46.21 | 45.40 | 45.61 | 8.505M |
| Aug 27, 2026 | 45.97 | 46.33 | 45.70 | 46.26 | 13.02M |
| Aug 26, 2026 | 47.80 | 48.04 | 46.87 | 47.19 | 8.878M |
| Aug 25, 2026 | 47.84 | 48.66 | 47.56 | 48.66 | 15.53M |
| Aug 24, 2026 | 47.09 | 47.30 | 46.56 | 46.92 | 9.674M |
| Aug 21, 2026 | 46.35 | 47.16 | 46.34 | 46.74 | 10.91M |
| Aug 20, 2026 | 46.89 | 46.90 | 46.11 | 46.14 | 9.670M |
| Aug 19, 2026 | 46.01 | 47.20 | 45.84 | 46.48 | 19.51M |
| Aug 18, 2026 | 44.91 | 46.06 | 44.76 | 45.71 | 12.09M |
| Aug 17, 2026 | 45.18 | 45.45 | 44.68 | 44.88 | 14.63M |
| Aug 14, 2026 | 46.90 | 47.04 | 45.75 | 45.89 | 10.85M |
| Aug 13, 2026 | 45.96 | 46.78 | 45.73 | 46.72 | 10.19M |
| Aug 12, 2026 | 45.87 | 46.55 | 45.56 | 46.39 | 9.564M |
| Aug 11, 2026 | 47.45 | 47.67 | 46.93 | 47.17 | 7.835M |
| Aug 10, 2026 | 47.00 | 47.74 | 46.66 | 47.73 | 10.19M |
| Aug 07, 2026 | 47.14 | 47.50 | 46.73 | 47.26 | 12.08M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 160.17 |
| GSK Plc | 48.13 |
| Johnson & Johnson | 265.58 |
| Eli Lilly & Co. | 1115.70 |
| Merck & Co., Inc. | 143.93 |
Price Related Metrics
| PE Ratio | 10.53 |
| PS Ratio | 3.721 |
| PEG Ratio | 0.8353 |
| Price to Book Value | 5.626 |
| Price to Free Cash Flow | 25.47 |
| Earnings Yield | 9.50% |
| Market Cap | 144.11B |
| PEGY Ratio | 0.6276 |
| Operating PE Ratio | 8.201 |
| Normalized PE Ratio | 10.12 |